Baidu
map
CURR OPIN ONCOL 润色咨询

CURRENT OPINION IN ONCOLOGY

出版年份：1989 年文章数：932 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：3.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    期刊发送的信件里需要注意几个方面的内容？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2014-06-03 匿名用户

    Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2012-06-20 匿名用户

    ONLY PUBLISH INVITED ARTICLES

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-29 neuron2010

    偏重的研究方向：肿瘤;癌症;

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1099332, encodeId=4afe109933247, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099331, encodeId=f858109933128, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503296, encodeId=59f950329616, content=Current Opinion in Oncology publishes invited articles only. We are unable to consider unsolicited manuscripts for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 08:52:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489018, encodeId=fac2489018c5, content=ONLY PUBLISH INVITED ARTICLES, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 20 09:43:00 CST 2012, time=2012-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482105, encodeId=102648210571, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:16:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476247, encodeId=6ccb4e6247f1, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=511326618, createdName=danyangwuqing, createdTime=Tue Jun 28 15:55:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-28 danyangwuqing

    偏重的研究方向：肿瘤;癌症;

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map